On September 10, 2020 Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, reported that James Dentzer, President and Chief Executive Officer of Curis, will provide a company overview at two upcoming investor conferences (Press release, Curis, SEP 10, 2020, View Source [SID1234564947]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cantor Fitzgerald Virtual Global Healthcare Conference: Fireside Chat – Tuesday, September 15, 2020 at 9:20 am ET.
H.C. Wainwright & Co. 22nd Annual Global Investment Conference: Tuesday, September 15, 2020 at 4:30 pm ET.
A live webcast of each presentation will be available under "Events & Presentations" in the Investors section of the Company’s website at www.curis.com. A replay of the webcast will be available on the Curis website for 90 days following the event.